PMC:7029759 / 11451-11648 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"265","span":{"begin":150,"end":159},"obj":"Species"}],"attributes":[{"id":"A265","pred":"tao:has_database_id","subj":"265","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" no available resources existing to manufacture the medications quickly.\n\nRepurposing currently available antiviral medications\nIdeal agents to fight 2019-nCoV would be approved small molecule drug"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T218","span":{"begin":134,"end":140},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T217","span":{"begin":150,"end":159},"obj":"SP_7"},{"id":"T216","span":{"begin":184,"end":192},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T147","span":{"begin":52,"end":63},"obj":"CHEBI:23888;CHEBI:23888"}],"text":" no available resources existing to manufacture the medications quickly.\n\nRepurposing currently available antiviral medications\nIdeal agents to fight 2019-nCoV would be approved small molecule drug"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T31","span":{"begin":106,"end":115},"obj":"Chemical"},{"id":"T32","span":{"begin":184,"end":192},"obj":"Chemical"}],"attributes":[{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A32","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"}],"text":" no available resources existing to manufacture the medications quickly.\n\nRepurposing currently available antiviral medications\nIdeal agents to fight 2019-nCoV would be approved small molecule drug"}

{"project":"LitCovid-sentences","denotations":[{"id":"T72","span":{"begin":74,"end":127},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" no available resources existing to manufacture the medications quickly.\n\nRepurposing currently available antiviral medications\nIdeal agents to fight 2019-nCoV would be approved small molecule drug"}